Zydus Lifesciences Limited, an Indian pharmaceutical company, has clinched final approval from the United States Food and Drug Administration (USFDA) for its Erythromycin Tablets USP, 250 mg and 500 mg. This latest approval elevates the company’s standing in the pharmaceutical industry, adding yet another feather to its cap. Erythromycin Tablets USP, 250 mg and 500 […]
Zydus Lifesciences said that it has secured final approval for Erythromycin Tablets USP, 250 mg and 500 mg from the US Food and Drug Administration (FDA). The reference listed drug (RLD) of the approved product is Erythromycin Tablets. Erythromycin Tablets USP, 250 mg and 500 mg are indicated for the prevention and treatment of infections […]
